In 2007 and 2008, two conferences for Asian new drug development were held in Tokyo. Several issues about Asian development were discussed from the sponsor's and the reviewer's point of view.
In the third conference, the active colleagues from other Asian countries (China, Chinese Taipei, Republic of Korea) joined in the program committee. The more critical and local based issues have been selected as Asian topics. The final goal is the contribution for Asian health care and patients.
Several experts in drug development invited from China, Republic of Korea, Chinese Taipei, Singapore, and other countries will give presentations sharing their experiences.
Main topics are as follows:
1) Epidemiological Research and Market Needs in Asian countries
2) Case Study: Asian Clinical Trials (Strategy/Operation)
3) Ask the Asian Regulators.
We are planning for opportunities for substantive discussion with PMDA regulators in order to develop new drugs which contribute to public health. At the reception on the first day, an informative discussion session entitled "What is the DIA World?” will be offered.
In the third conference, the active colleagues from other Asian countries (China, Chinese Taipei, Republic of Korea) joined in the program committee. The more critical and local based issues have been selected as Asian topics. The final goal is the contribution for Asian health care and patients.
Several experts in drug development invited from China, Republic of Korea, Chinese Taipei, Singapore, and other countries will give presentations sharing their experiences.
Main topics are as follows:
1) Epidemiological Research and Market Needs in Asian countries
2) Case Study: Asian Clinical Trials (Strategy/Operation)
3) Ask the Asian Regulators.
We are planning for opportunities for substantive discussion with PMDA regulators in order to develop new drugs which contribute to public health. At the reception on the first day, an informative discussion session entitled "What is the DIA World?” will be offered.
